Clinical trial
An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept)…
NCT00346294 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00346294 |
|---|---|
| Title | An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis |
| Official title | An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis |
| Lead sponsor | Amgen, Industry |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 115 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jun 29, 2006 |
| Last update posted | Jan 22, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: